The Lustgarten Foundation is the largest private funder of pancreatic cancer research in the world.
To date, we’ve invested over $301M in high-risk, high-reward research to accelerate and expand life-saving treatment options. We lead a unique, collaborative, science-focused strategy and have been a driving force in every major advancement in pancreatic cancer research since 1998.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
Lustgarten Announcements
In this interactive Lustgarten LIVE symposium, moderated by Lustgarten’s VP, Research, Andrew Rakeman, PhD, postdoctoral researchers from our six premier Lustgarten LABS will compete in The Lustgarten Sprint to Discovery, […]
The results of the Pancreatic Adenocarcinoma Signature Stratification for Treatment (PASS-01) clinical trial were published today in the Journal of Clinical Oncology, marking a major milestone in the pursuit of […]
Federal funding cuts to cancer research are devastating—but we’re not giving up, and neither should you! Know the facts – Why it matters and who it hurts – In moments […]
Abby’s story
From Nurse to Patient
Abby was in complete shock when she was diagnosed. It never occurred to her as a young, active person with no family history of the disease, that she could have a PNET. Despite being scared, she never wavered in her belief that an excellent medical team, positive thinking, hope and her strong faith would carry her through.
Read Abby’s StoryNews from Our Partners
Let’s Win Pancreatic Cancer
Let’s Win Pancreatic Cancer Introduces New Features to Help Patients
Let’s Win Pancreatic Cancer has released their enhanced patient-centered navigation and two powerful new tools. These changes allow Let’s Win to further its mission of guiding patients and caregivers with vital information for better outcomes.
» Check out these New Features to Help Patients «
Trial Finder: https://letswinpc.org/treatments/finding-a-clinical-trial/
Doctor Finder: https://letswinpc.org/finding-pancreatic-cancer-specialist/
Highlights from the 2025 AACR Annual Meeting
The sharing of data and ideas was the central focus of the American Association of Cancer Research (AACR) Annual Meeting 2025. The meeting brought together more than 20,000 cancer experts and industry leaders from around the world to learn about the fundamental research being conducted. This year’s theme was “Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact.”
Pancreatic Cancer Research Highlights from ASCO 2025 Meeting
The American Society of Clinical Oncology (ASCO) Annual Meeting brought together physician-scientists and researchers from across the world to showcase potentially promising treatment breakthroughs for many different types of cancer.
» Learn more about pancreatic cancer research updates from ASCO 2025 «